Mutaflor
Mutaflor, licence 80044904: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Aralez Pharmaceuticals Canada Inc.
- NPN or DIN-HM
- 80044904
- Status
- Active licence
- Licence date
- 23 September 2013
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Escherichia coli Source : Escherichia coli Nissle 1917 | 25.0 Milliards d'UFC ; minimum: 25.0 Milliards d'UFC | Not calculated |
Non-medicinal ingredients
Talc, Shellac, Copolymère d'acide méthacrylique, Maltodextrine, glycérol, Citrate de triéthyle, Oxyde de fer (Fe2O3), Macrogol 4000, White beeswax, Cire de Carnauba, Gélatine, Dioxyde de titane
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18.0 Année(s) | 2.0 Capsule | minimum: 2.0 Jour(s) ; maximum: 3.0 Jour(s) |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to manage and provide relief from chronic constipation. Helps to reduce abdominal pain/cramps during instances of chronic constipation.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80044904
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.